Obesity Drugmakers Still a ‘Buy’ Despite Lofty Valuations
April 18, 2024
Baum, Andrew
Pricing Restrictions, Economic Concerns Weigh on Biotech Sector
March 30, 2023
Nierengarten, David
Gene Editing Companies Enjoy Momentum While Gene Therapies Lag
September 30, 2021
Livshits, Geulah
D.C. Drug Price Debate Creates Opportunity for Longer-Term Pharma Investors
September 30, 2021
Kedra, Kevin
Pharma M&A Activity Expected to Return in 2021
September 21, 2020
Kedra, Kevin
